Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cosmetics Industry Stakeholders Not Thrilled About Senate Reform Bill, And Why Should They Be?

Jun 10 2022

• By Ryan Nelson and Lauren Nardella

Related Content

Senate HELP Hearing Focuses On WEN, High-Profile Cosmetic Safety Issues

Sep 23 2016

House User Fee Mark-Up: Few Tweaks, But Concerns About ALS And Accelerated Approval

May 19 2022

Plaintiff Claims Against Beiersdorf For ‘Unlawfully Marketed Drug’ Are Preempted By FDCA, Court Rules

Apr 24 2020

Senate HELP Draft For Cosmetics Reform Does Not Go Far Enough – NGOs

May 27 2022

Senate HELP Floats Draft For US Cosmetics Reform; Top Trade Groups Hustle To Respond

May 19 2022

US House Cosmetics Hearing: Preemption, FDA Ingredient Review Could Be Regulatory Reform Snags

Dec 05 2019

Prostaglandin Analogues In Eyelash Cosmetics: Rodan & Fields To Settle Litigation For $38M

Mar 31 2022

Additional Topics

United States US States Cosmetics Legislation FDA NGOs Cosmetic Ingredients Safety Consumer

More from Legislation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window